IL-15-Induced IL-10 increases the cytolytic activity of human natural killer cells

Molecules and Cells

Volumn 32, Issue 3, 2011, Pages 265-272

  Park, Ju Yeong ^a,b   Lee, Suk Hyung ^a   Yoon, Suk Ran ^a,b   Park, Young Jun ^a,b   Jung, Haiyoung ^a,b   Kim, Tae Don ^a   Choi, Inpyo ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

Cytotoxicity; IL 10; IL 15; Natural killer cell

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 15; STAT PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANTIBODIES, NEUTRALIZING; CELL LINE; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-15; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855644010     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-011-1057-8     Document Type: Article

References (32)

1. Alter, G., Kavanagh, D., Rihn, S., Luteijn, R., Brooks, D., Oldstone, M., van Lunzen, J., and Altfeld, M. (2010). IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J. Clin. Invest. 120, 1905-1913.
2. Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L., and Powrie, F. (1999). An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004.
3. Becknell, B., and Caligiuri, M.A. (2005). Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv. Immunol. 86, 209-239. (Pubitemid 40215694)
4. D'Andrea, A., Aste-Amezaga, M., Valiante, N.M., Ma, X., Kubin, M., and Trinchieri, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048. (Pubitemid 23260442)
5. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M.G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and de Vries, J.E. (1991). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924.
6. Dubois, S., Patel, H.J., Zhang, M., Waldmann, T.A., and Muller, J.R. (2008). Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action. J. Immunol. 180, 2099-2106.
7. Fiorentino, D.F., Bond, M.W., and Mosmann, T.R. (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095.
8. Hunter, C.A., Ellis-Neyer, L., Gabriel, K.E., Kennedy, M.K., Grabstein, K.H., Linsley, P.S., and Remington, J.S. (1997a). The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. J. Immunol. 158, 2285-2293. (Pubitemid 127470013)
9. Hunter, C.A., Gabriel, K.E., Radzanowski, T., Neyer, L.E., and Remington, J.S. (1997b). Type I interferons enhance production of IFN-gamma by NK cells. Immunol. Lett. 59, 1-5. (Pubitemid 27407676)
10. Hunter, C.A., Timans, J., Pisacane, P., Menon, S., Cai, G., Walker, W., Aste-Amezaga, M., Chizzonite, R., Bazan, J.F., and Kastelein, R.A. (1997c). Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. Eur. J. Immunol. 27, 2787-2792. (Pubitemid 27478344)
11. Kennedy, M.K., Glaccum, M., Brown, S.N., Butz, E.A., Viney, J.L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C.R., et al. (2000). Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771-780.
12. Lanier, L.L., and Phillips, J.H. (1992). Natural killer cells. Curr. Opin. Immunol. 4, 38-42.
13. Ma, A., Boone, D.L., and Lodolce, J.P. (2000). The pleiotropic functions of interleukin 15: Not so interleukin 2-like after all. J. Exp. Med. 191, 753-756.
14. Ma, A., Koka, R., and Burkett, P. (2006). Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24, 657-679.
15. Mocellin, S., Panelli, M., Wang, E., Rossi, C.R., Pilati, P., Nitti, D., Lise, M., and Marincola, F.M. (2004). IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes Immun. 5, 621-630. (Pubitemid 40045300)
16. Moore, K.W., O'Garra, A., de Waal Malefyt, R., Vieira, P., and Mosmann, T.R. (1993). Interleukin-10. Annu. Rev. Immunol. 11, 165-190. (Pubitemid 23115005)
17. Murray, P.J., Wang, L., Onufryk, C., Tepper, R.I., and Young, R.A. (1997). T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 158, 315-321. (Pubitemid 127483871)
18. Nagalakshmi, M.L., Murphy, E., McClanahan, T., and de Waal Malefyt, R. (2004). Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int. Immunopharmacol. 4, 577-592. (Pubitemid 38553881)
19. Nandi, D., Gross, J.A., and Allison, J.P. (1994). CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152, 3361-3369. (Pubitemid 24098032)
20. Neyer, L.E., Grunig, G., Fort, M., Remington, J.S., Rennick, D., and Hunter, C.A. (1997). Role of interleukin-10 in regulation of T-celldependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65, 1675-1682. (Pubitemid 27193585)
21. Ortaldo, J.R., and Longo, D.L. (1988). Human natural lymphocyte effector cells: Definition, analysis of activity, and clinical effectiveness. J. Natl. Cancer Inst. 80, 999-1010.
22. Pillet, A.H., Bugault, F., Theze, J., Chakrabarti, L.A., and Rose, T. (2009). A programmed switch from IL-15-to IL-2-dependent activation in human NK cells. J. Immunol. 182, 6267-6277.
23. Scharton, T.M., and Scott, P. (1993). Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-577. (Pubitemid 23218205)
24. Scharton-Kersten, T.M., and Sher, A. (1997). Role of natural killer cells in innate resistance to protozoan infections. Curr. Opin. Immunol. 9, 44-51. (Pubitemid 27095896)
25. Schulz, U., Kreutz, M., Multhoff, G., Stoelcker, B., Kohler, M., Andreesen, R., and Holler, E. (2010). Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands. Scand. J. Immunol. 72, 319-331.
26. Spits, H., Lanier, L.L., and Phillips, J.H. (1995) Development of human T and natural killer cells. Blood 85, 2654-2670.
27. Sun, R., Fan, J., Wei, H., Zhang, C., and Tian, Z. (2003) Use of interleukin-15 for preparation of adherent NK cells from human peripheral blood: Comparison with interleukin-2. J. Immunol. Methods 279, 79-90. (Pubitemid 37297492)
28. Tripp, C.S., Wolf, S.F., and Unanue, E.R. (1993) Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunode ficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90, 3725-3729. (Pubitemid 23111440)
29. Waldmann, T.A. (2006). The biology of interleukin-2 and interleukin-15: Implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6, 595-601. (Pubitemid 44134092)
30. Waldmann, T.A., Dubois, S., and Tagaya, Y. (2001). Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy. Immunity 14, 105-110. (Pubitemid 32206513)
31. Weber-Nordt, R.M., Riley, J.K., Greenlund, A.C., Moore, K.W., Darnell, J.E., and Schreiber, R.D. (1996). Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J. Biol. Chem. 271, 27954-27961. (Pubitemid 26367376)
32. Yang, A.S., and Lattime, E.C. (2003). Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. Cancer Res. 63, 2150-2157. (Pubitemid 36538620)